Oxford Launches First Human Trials for Bundibugyo Ebola Vaccine Amid Outbreak

Oxford University has initiated the first human trials for a vaccine targeting the Bundibugyo strain of the Ebola virus. This comes as the majority of new Ebola cases in eastern Congo are from unknown chains, indicating the outbreak is outpacing the response.